Understanding Fish Consumption Habits During Pregnancy

This study has been completed.
Sponsor:
Collaborators:
HSPH-NIEHS Center for Environmental Health
Information provided by:
Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:
NCT01178398
First received: August 3, 2010
Last updated: August 9, 2010
Last verified: August 2010
  Purpose

Many pregnant women in the US do not consume enough docosahexaenoic acid (DHA), an essential nutrient found in fish. Apparently conflicting findings that fish consumption is beneficial for the developing fetus, yet potentially toxic because of mercury contamination, have created uncertainty about the appropriate fish consumption advice to provide pregnant women. The investigators objective was to determine knowledge, behaviors, and received advice regarding fish consumption among pregnant women who are infrequent consumers of fish.


Condition
Nutrition

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: A Qualitative Study of Fish Consumption During Pregnancy

Resource links provided by NLM:


Further study details as provided by Harvard Pilgrim Health Care:

Enrollment: 22
Study Start Date: October 2009
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Fish is a healthful food that is the primary dietary source of elongated n-3 polyunsaturated fatty acids (PUFA), nutrients essential for optimal neurodevelopment. Most pregnant women in the US do not consume adequate n-3 PUFA. However, fish also may be contaminated with methylmercury, and approximately 10% of women of childbearing age in the US have mercury levels higher than recommended. Because the same food contains both essential nutrients and harmful contaminants, substantial confusion reigns about the best course of action for pregnant women. Additionally, it is not clear what fish consumption advice would be most effective in changing women's fish consumption habits. The goal of this pilot study is to perform formative work to allow us to develop and refine an intervention to promote consumption of fish low in mercury and high in n-3 PUFA among pregnant women. This project, together with a pilot RCT already funded, will serve as preliminary data to support a larger RCT to evaluate the effects of the intervention on pregnancy outcomes and postpartum maternal and infant health.

Specific Aims Aim 1. Among pregnant women, identify: 1) knowledge of the potential risks and benefits associated with fish consumption during pregnancy; 2) awareness of current recommendations for fish consumption by pregnant women; 3) the sources of information from which they are learning about the health effects associated with fish intake; and 4) facilitators and barriers to fish consumption, such as cost, availability, taste, and habits. To achieve this aim, we will conduct focus groups with pregnant women in the Boston area who are infrequent consumers of fish (defined as <= 2 monthly fish servings).

Aim 2. Develop materials for a planned intervention to increase consumption of fish high in n-3 polyunsaturated fatty acids and low in methylmercury among pregnant women who are infrequent consumers of fish at baseline. We will use results from Aim 1 to inform the development of these materials.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Women aged 18+ who are currently pregnant and who consume <2 weekly fish servings

Criteria

Inclusion Criteria:

  • currently pregnant
  • age at least 18 years

Exclusion Criteria:

  • unable to speak or understand English
  • consuming 2 or more weekly fish servings
  • unable to eat fish (e.g. allergy, dietary restriction)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01178398

Locations
United States, Massachusetts
Harvard Pilgrim Health Care Institute
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Harvard Pilgrim Health Care
HSPH-NIEHS Center for Environmental Health
Investigators
Principal Investigator: Emily Oken, MD, MPH Harvard Pilgrim Health Care Institute
  More Information

No publications provided

Responsible Party: Emily Oken, Harvard Pilgrim Health Care Institute
ClinicalTrials.gov Identifier: NCT01178398     History of Changes
Other Study ID Numbers: 0613, P30ES000002
Study First Received: August 3, 2010
Last Updated: August 9, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Harvard Pilgrim Health Care:
fish
pregnancy
nutrition
mercury
focus group
omega-3 fatty acid
docosahexaenoic acid (DHA)

ClinicalTrials.gov processed this record on August 26, 2014